LAXMI DENTAL LIMITED Announced it’s INITIAL PUBLIC OFFERING (IPO) TO OPEN ON MONDAY, JANUARY 13th, 2025 Sets Price Band fixed at ₹ 407 to ₹ 428 per equity share of face value of ₹2 each

Mumbaoi, 8th January 2025 (GNI) : (L-R) –Mr Viral Shah, Executive Director & Head-ECM Syndication, Nuvama Wealth Management Limited, Mr Rahul Choudhary, Executive Director, Motilal Oswal Investment Advisors Limited, Mr. Rajesh Khakhar, Chairperson and Whole-time Director, Laxmi Dental Limited, Mr. Sameer Merchant, Managing Director and Chief Executive Officer, Laxmi Dental Limited, Mr. Dharmesh Dattani, Chief Financial Officer, Laxmi Dental Limited, Mr Ratnadeep Archaryya, Senior Vice President, SBI Capital Market Limited During their ipo conference in Mumbai – photo by Sumant Gajinkar GNI

Mumbai, 8th January 2025 (GNI) : (L-R) Mr. Rajesh Khakhar, Chairperson and Whole-time Director, Laxmi Dental Limited, Mr. Sameer Merchant, Managing Director and Chief Executive Officer, Laxmi Dental LimitedMr. Dharmesh Dattani, Chief Financial Officer, Laxmi Dental Limited during their IPO conference in Mumbai – photo by Sumant Gajinkar GNI

LAXMI DENTAL LIMITED Announced it’s INITIAL PUBLIC OFFERING (IPO) TO OPEN ON MONDAY, JANUARY 13^th, 2025

·         Price Band fixed at ₹ 407 to ₹ 428 per equity share of face value of ₹2 each.

·         The Bid /Offer Period will open on Monday, January 13^th, 2025 and close on Wednesday, January 15^th, 2025. The Anchor Investor Bid/Offer Period opens and closes on Friday, January 10^th, 2025.

·         Bids can be made for a minimum of 33 Equity Shares and in multiples of 33 Equity Shares thereafter.

·         RHP Link: https://www.laxmidentallimited.com/public/investors/offer_documents/rhp/Project-Lotus-RHP(withfinancials).pdf

National, January 08, 2025 (GNI) : Laxmi Dental Limited (“LDL” or “The Company”), shall open the Bid Offer Period in relation to its Initial Public Offer of the Equity Shares on Monday,  January 13^th, 2025.

The Price Band of the Offer has been fixed at ₹ 407 to ₹ 428 per Equity Share (the “Price Band”). Bids can be made for a minimum of 33 Equity Shares and in multiples of 33 Equity Shares thereafter. (The “Bid Lot”).

The total offer size of equity shares (face value ₹2 each) comprises of Fresh Issue aggregating up to ₹1,380 million [₹138 Crore] and Offer for Sale up to 13,085,467 [1.31 lakhs number of equity shares] (“Offer for Sale”) by Selling Shareholders. (“Total Offer Size”)

The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding, (i) Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by the Company estimated to be ₹229.84 million [₹22.98 crore]; (ii) Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings estimated to be ₹46 million [₹4.60 crore]; (iii) Funding the capital expenditure requirements for purchase of new machinery for the Company estimated to be ₹435.07 million [₹43.51 crore]; (iv) Investment in Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery estimated to be ₹250.04 million [₹25.00 crore] and balance amount towards general corporate purposes.

The Offer for Sale comprises of upto 196,604 Equity Shares by Rajesh Vrajlal Khakhar, upto 434,598 Equity Shares by Sameer Kamlesh Merchant (Together “Promoter Selling Shareholder”); upto 11,614,267 Equity Shares by OrbiMed Asia II Mauritius Limited (“Investor Selling Shareholders”); upto 239,838 Equity Shares by Jigna Rajesh Khakhar, upto 150,040 Equity Shares by Hasmukh Vrajlal Khakhar, upto 150,040 Equity Shares by Amrish Mahendrabhai Desai, upto 150,040 Equity Shares Parag Jamnadas Bhimjiyani and upto 150,040 Equity Shares by Kunal Kamlesh Merchant (All Together, “Other Selling Shareholders”)

size of more than ₹200,000 and up to ₹1,000,000; and (b) two-third of such portion shall be reserved for applicants with application size of more than ₹1,000,000, provided that the unsubscribed portion in either of such sub-categories may be allocated to applicants in the other sub-category of Non-Institutional Bidders and not more than 10% of the Offer shall be available for allocation to Retail Individual Bidders in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price.

All potential Bidders (except Anchor Investors) are required to mandatorily utilise the Application Supported by Blocked Amount (“ASBA”) process providing details of their respective ASBA accounts, and UPI ID (in case of UPI Bidders) if applicable, in which the corresponding Bid Amounts will be blocked by the SCSBs or by the Sponsor Bank(s) under the UPI Mechanism, as applicable, to the extent of the respective Bid Amounts. Anchor Investors are not permitted to participate in the Offer through the ASBA process. For details, see “Offer Procedure” beginning on page 544.ends GNI